(19)
(11) EP 4 152 948 A1

(12)

(43) Date of publication:
29.03.2023 Bulletin 2023/13

(21) Application number: 21828842.1

(22) Date of filing: 25.06.2021
(51) International Patent Classification (IPC): 
A23K 50/75(2016.01)
A61K 39/012(2006.01)
C07K 14/455(2006.01)
A61K 39/00(2006.01)
A61P 33/02(2006.01)
C12N 15/09(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/739; A61K 39/39; A61K 39/02; A61K 2039/552; A61P 37/02; A23K 50/75; A23K 20/158; A23K 20/163
(86) International application number:
PCT/US2021/039180
(87) International publication number:
WO 2021/263162 (30.12.2021 Gazette 2021/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.06.2020 US 202063044841 P

(71) Applicant: Zivo Bioscience, Inc.
Bloomfield Hills, MI 48304 (US)

(72) Inventors:
  • STEFFEK, Amy E.
    Bloomfield Hills, MI 48304 (US)
  • DAHL, Andrew A.
    Bloomfield Hills, MI 48304 (US)
  • PFUND, William P.
    Bloomfield Hills, MI 48304 (US)

(74) Representative: Prüfer & Partner mbB Patentanwälte · Rechtsanwälte 
Sohnckestraße 12
81479 München
81479 München (DE)

   


(54) IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR